The DOI matches its Crossref record; 373 of the 373 references it cites were found in a registry or an index.
Malignant melanoma: genetics and therapeutics in the genomic era
Open accessAbstract
Cell for cell, probably no human cancer is as aggressive as melanoma. It is among a handful of cancers whose dimensions are reported in millimeters. Tumor thickness approaching 4 mm presents a high risk of metastasis, and a diagnosis of metastatic melanoma carries with it an abysmal median survival of 6–9 mo. What features of this malignancy account for such aggressive behavior? Is it the migratory history of its cell of origin or the programmed adaptation of its differentiated progeny to environmental stress, particularly ultraviolet radiation? While the answers to these questions are far from complete, major strides have been made in our understanding of the cellular, molecular, and genetic underpinnings of melanoma. More importantly, these discoveries carry profound implications for the development of therapies focused directly at the molecular engines driving melanoma, suggesting that we may have reached the brink of an unprecedented opportunity to translate basic science into clinical advances. In this review, we attempt to summarize our current understanding of the genetics and biology of this disease, drawing from expanding genomic information and lessons from development and genetically engineered mouse models. In addition, we look forward toward how these new insights will impact on therapeutic options for metastatic melanoma in the near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–373 of 373
Altered states: selectively drugging the Hsp90 cancer chaperone
Workman, P. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.12.005 · Cited by 195
O'Brien, S. M., Cunningham, C. C., Golenkov, A. K., Turkina, A. G., Novick, S. C., & Rai, K. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.4364 · Cited by 194
Malignant melanoma: modern black plague and genetic black box
Chin, L., Merlino, G., & DePinho, R. A. (1998) · Genes & Development · doi:10.1101/gad.12.22.3467 · Cited by 194
Self-citationRamanathan, R. K., Trump, D. L., Eiseman, J. L., Belani, C. P., Agarwala, S. S., Zuhowski, E. G., Lan, J., Potter, D. M., Ivy, S. P., Ramalingam, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2322 · Cited by 194
Llauger, L., He, H., Kim, J., Aguirre, J., Rosen, N., Peters, U., Davies, P., & Chiosis, G. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049012b · Cited by 191
Ma, X., Ziel-van der Made, A. C., Autar, B., van der Korput, H. A., Vermeij, M., van Duijn, P., Cleutjens, K. B., de Krijger, R., Krimpenfort, P., Berns, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4519 · Cited by 191
Lineage-specific Signaling in Melanocytes
Price, E. R., Ding, H.-F., Badalian, T., Bhattacharya, S., Takemoto, C., Yao, T.-P., Hemesath, T. J., & Fisher, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.17983 · Cited by 191
Self-citationFunctional and therapeutic significance of Akt deregulation in malignant melanoma
Robertson, G. P. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-1577-9 · Cited by 189
Koprowski, H., Herlyn, M., Balaban, G., Parmiter, A., Ross, A., & Nowell, P. (1985) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01534687 · Cited by 188
Effects of G-protein mutations on skin color
Van Raamsdonk, C. D., Fitch, K. R., Fuchs, H., de Angelis, M. H., & Barsh, G. S. (2004) · Nature Genetics · doi:10.1038/ng1412 · Cited by 183
OTX2 Activates the Molecular Network Underlying Retina Pigment Epithelium Differentiation
Martínez-Morales, J. R., Dolez, V., Rodrigo, I., Zaccarini, R., Leconte, L., Bovolenta, P., & Saule, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301708200 · Cited by 181
ABL Oncogenes and Phosphoinositide 3-Kinase: Mechanism of Activation and Downstream Effectors
Kharas, M. G., & Fruman, D. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3888 · Cited by 181
Absence of BRAF mutations in UV-protected mucosal melanomas
Edwards, R. H., Ward, M. R., Wu, H., Medina, C. A., Brose, M. S., Volpe, P., Nussen-Lee, S., Haupt, H. M., Martin, A. M., Herlyn, M., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.016667 · Cited by 178
Buscà, R., Berra, E., Gaggioli, C., Khaled, M., Bille, K., Marchetti, B., Thyss, R., Fitsialos, G., Larribère, L., Bertolotto, C., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200501067 · Cited by 178
Analysis of N- and K-Ras Mutations in the Distinctive Tumor Progression Phases of Melanoma
Stas, M., Degreef, H., Demunter, A., De Wolf-Peeters, C., & van den Oord, J. J. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01601.x · Cited by 176
Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
Mills, L., Tellez, C. S., Huang, S., Baker, C. H., McCarty, M. F., Green, L., Gudas, J. M., Feng, X., & Bar‐Eli, M. (2002) · PubMed · Cited by 176
Sumoylation of MITF and Its Related Family Members TFE3 and TFEB
Miller, A. J., Levy, C., Davis, I. J., Razin, E., & Fisher, D. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411757200 · Cited by 175
Self-citationGimotty, P. A., Van Belle, P., Elder, D. E., Murry, T., Montone, K. T., Xu, X., Hotz, S., Raines, S., Ming, M. E., Wahl, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0735 · Cited by 175
Ludwig, A., Rehberg, S., & Wegner, M. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01446-7 · Cited by 174
c-Met Expression Is Regulated by Mitf in the Melanocyte Lineage
McGill, G. G., Haq, R., Nishimura, E. K., & Fisher, D. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513094200 · Cited by 174
Self-citationMolecular genetics of familial cutaneous melanoma.
Haluska, F. G., & Hodi, F. S. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.670 · Cited by 172
Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice
You, M. J., Castrillón, D. H., Bastian, B. C., O’Hagan, R. C., Bosenberg, M., Parsons, R. E., Chin, L., & DePinho, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022632099 · Cited by 171
Self-citationIdentification of p90RSK as the probable CREB-Ser133 kinase in human melanocytes.
Böhm, M., Moellmann, G. E., Cheng, E., Alvarez‐Franco, M., Wagner, S., Sassone‐Corsi, P., & Halaban, R. (1995) · PubMed · Cited by 171
A melanoma-associated germline mutation in exon 1β inactivates p14ARF
Rizos, H., Puig, S., Badenas, C., Malvehy, J., Darmanian, A. P., Jiménez, L., Milà, M., & Kefford, R. F. (2001) · Oncogene · doi:10.1038/sj.onc.1204728 · Cited by 171
Verastegui, C., Bille, K., Ortonne, J.-P., & Ballotti, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000445200 · Cited by 170
Lack of BRAF mutations in uveal melanoma.
Rimoldi, D., Salvi, S., Líénard, D., Lejeune, F. J., Speiser, D. E., Zografos, L., & Cerottini, J. (2003) · PubMed · Cited by 169
Huang, S., Luca, M., Gutman, M., McConkey, D. J., Langley, K. E., Lyman, S. D., & Bar‐Eli, M. (1996) · PubMed · Cited by 167
Treatment of lentigo maligna with topical imiquimod
Naylor, M. F., Crowson, N., Kuwahara, R., Teague, K., Garcia, C., Mackinnis, C., Haque, R., Odom, C., Jankey, C., & Cornelison, R. L. (2003) · British Journal of Dermatology · doi:10.1046/j.0366-077x.2003.05637.x · Cited by 167
Dual Inactivation of RB and p53 Pathways in RAS-Induced Melanomas
Bardeesy, N., Bastian, B. C., Hezel, A., Pinkel, D., DePinho, R. A., & Chin, L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.2144-2153.2001 · Cited by 166
Self-citationTolcher, A. W., Chi, K., Kuhn, J., Gleave, M., Patnaik, A., Takimoto, C., Schwartz, G., Thompson, I., Berg, K., D'Aloisio, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2145 · Cited by 166
Lee, M., Goodall, J., Verastegui, C., Ballotti, R., & Goding, C. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003816200 · Cited by 165
The specificity of p53 mutation spectra in sunlight induced human cancers
Daya-Grosjean, L., Dumaz, N., & Sarasin, A. (1995) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/1011-1344(95)07130-t · Cited by 164
Banerji, U., Walton, M., Raynaud, F., Grimshaw, R., Kelland, L., Valenti, M., Judson, I., & Workman, P. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0518 · Cited by 164
Invasive melanoma in Cdk4-targeted mice
Sotillo, R., García, J. F., Ortega, S., Martín, J., Dubus, P., Barbacid, M., & Malumbres, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241338598 · Cited by 164
INHERITED HEARING DEFECTS IN MICE
Steel, K. P. (1995) · Annual Review of Genetics · doi:10.1146/annurev.ge.29.120195.003331 · Cited by 164
Zhang, X. D., Borrow, J. M., Zhang, X. Y., Nguyen, T., & Hersey, P. (2003) · Oncogene · doi:10.1038/sj.onc.1206427 · Cited by 163
Takeda, K. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.1.125 · Cited by 161
van Elsas, A., Zerp, S. F., van der Flier, S., Krüse, K. M., Aarnoudse, C. A., Hayward, N. K., Ruiter, D. J., & Schrier, P. I. (1996) · Europe PMC (PubMed Central) · Cited by 160
Gray‐Schopfer, V. C., Dias, S. D. R., & Marais, R. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-5865-1 · Cited by 160
Sharpless, N. E., & DePinho, R. A. (2005) · Nature · doi:10.1038/436636a · Cited by 159
Paumelle, R., Tulashe, D., Kherrouche, Z., Plaza, S., Leroy, C., Reveneau, S., Vandenbunder, B., & Fafeur, V. (2002) · Oncogene · doi:10.1038/sj.onc.1205297 · Cited by 158
Malignant melanoma in transgenic mice.
Bradl, M., Klein–Szanto, A. J., Porter, S. D., & Mintz, B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.1.164 · Cited by 152
Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors
Xu, G. H., Zhang, W., Bertram, P. G., Zheng, X.-F., & McLeod, H. L. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.4.893 · Cited by 152
Amplification of CDK4 and MDM2 in malignant melanoma
Muthusamy, V., Hobbs, C., Nogueira, C., Cordon‐Cardo, C., McKee, P. H., Chin, L., & Bosenberg, M. W. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20310 · Cited by 148
Self-citationToll-like receptors: balancing host resistance with immune tolerance
Pasare, C., & Medzhitov, R. M. (2003) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.09.002 · Cited by 148
Genetics of dark skin in micePreprint
Fitch, K. R., McGowan, K. A., van Raamsdonk, C. D., Fuchs, H., Lee, D., Puech, A., Hérault, Y., Threadgill, D. W., de Angelis, M. H., & Barsh, G. S. (2003) · Genes & Development · doi:10.1101/gad.1023703 · Cited by 146
Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma
Leiter, U., Schmid, R. M., Kaskel, P., Peter, R. U., & Krähn, G. M. (2000) · Archives of Dermatological Research · doi:10.1007/s004030050479 · Cited by 144
Papp, T., Pemsel, H., Zimmermann, R., Bastrop, R., Weiss, D. G., & Schiffmann, D. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.8.610 · Cited by 144
Eisenmann, K. M., VanBrocklin, M. W., Staffend, N. A., Kitchen, S. M., & Koo, H.-M. (2003) · PubMed · Cited by 143
Ink4a/Arf links senescence and aging
Sharpless, N. E. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.06.025 · Cited by 142
Glinsky, G. V. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)04738-1 · Cited by 142
Luchin, A. I., Suchting, S., Merson, T. D., Rosol, T. J., Hume, D. A., Cassady, A. I., & Ostrowski, M. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106418200 · Cited by 142
Uribe, P., Wistuba, I. I., & González, S. (2003) · American Journal of Dermatopathology · doi:10.1097/00000372-200310000-00001 · Cited by 142
High BRAF mutation frequency does not characterize all melanocytic tumor types
Saldanha, G. S., Purnell, D., Fletcher, A., Potter, L., Gillies, A., & Pringle, J. H. (2004) · International Journal of Cancer · doi:10.1002/ijc.20325 · Cited by 141
Marcucci, G., Stock, W., Dai, G., Klisovic, R. B., Liu, S., Klisovic, M. I., Blum, W. G., Kefauver, C. A., Sher, D. A., Green, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.118 · Cited by 141
Kadekaro, A. L., Kanto, H., Kavanagh, R. J., & ABDEL‐MALEK, Z. A. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03200.x · Cited by 140
Schön, M. P., Wienrich, B. G., Drewniok, C., Bong, A. B., Eberle, J., Geilen, C. C., Gollnick, H. P. M., & Schön, M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22528.x · Cited by 138
Functional variation of MC1R alleles from red-haired individuals
Healy, E. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.21.2397 · Cited by 138
Results of clinical trials with an allogeneic melanoma tumor cell lysate vaccine: Melacine®
Sondak, V. K., & Sosman, J. A. (2003) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.09.004 · Cited by 137
Lack of BRAF Mutation in Primary Uveal Melanoma
Cohen, Y., Goldenberg‐Cohen, N., Parrella, P., Chowers, I., Merbs, S. L., Pe’er, J., & Sidransky, D. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1329 · Cited by 135
Deletion of the SLUG (SNAI2) gene results in human piebaldism
Sánchez‐Martín, M., Pérez‐Losada, J., Rodríguez-García, A., González‐Sánchez, B., Korf, B. R., Küster, W., Moss, C., Spritz, R. A., & Sánchez-García, I. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20345 · Cited by 135
Non-ocular cancer in relatives of retinoblastoma patients
Sanders, B. M., Jay, M., Draper, G. J., & Roberts, E. P. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.285 · Cited by 134
Selzer, E., Schlagbauer‐Wadl, H., Okamoto, I., Pehamberger, H., P�tter, R., & Jansen, B. (1998) · Melanoma Research · doi:10.1097/00008390-199806000-00001 · Cited by 134
Germline mutation of ARF in a melanoma kindred
Hewitt, C., Wu, C. L., Evans, G., Howell, A., ELLES, R. G., Jordan, R., Sloan, P., Read, A. P., & Thakker, N. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.11.1273 · Cited by 133
Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer
Bastian, B. C. (2003) · Oncogene · doi:10.1038/sj.onc.1206463 · Cited by 130
Atkins, M. B., O’Boyle, K., Sosman, J. A., Weiss, G. R., Margolin, K. A., Ernest, M. L., Kappler, K., Mier, J. W., Sparano, J. A., & Fisher, R. I. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.8.1553 · Cited by 128
Young, J. P., Barker, M., Simms, L. A., Walsh, M. D., Biden, K. G., Buchanan, D. D., Buttenshaw, R. L., Whitehall, V., Arnold, S., JACKSON, L., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00673-1 · Cited by 128
Fuse, N., Yasumoto, K., Suzuki, H., Takahashi, K., & Shibahara, S. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0298 · Cited by 128
A Tissue-restricted cAMP Transcriptional Response
Huber, W. E., Price, E. R., Widlund, H. R., Du, J., Davis, I. J., Wegner, M., & Fisher, D. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309036200 · Cited by 125
Self-citationMet–HGF/SF: Tumorigenesis, Invasion and Metastasis
Woude, G. F. V., Jeffers, M., Cortner, J., Alvord, G., Tsarfaty, I., & Resau, J. H. (2007) · Novartis Foundation symposium · doi:10.1002/9780470515457.ch8 · Cited by 124
Genomic analysis of the Microphthalmia locus and identification of the MITF-J/Mitf-J isoform
Hershey, C. L., & Fisher, D. E. (2005) · Gene · doi:10.1016/j.gene.2004.12.002 · Cited by 122
Self-citationZhai, S., Yaar, M., Doyle, S. M., & Gilchrest, B. A. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0143 · Cited by 121
Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model
Kannan, K., Sharpless, N. E., Xu, J., O’Hagan, R. C., Bosenberg, M., & Chin, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0336397100 · Cited by 120
Self-citationGangarosa, L. M., Sizemore, N., Graves‐Deal, R., Oldham, S., Der, C. J., & Coffey, R. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18926 · Cited by 118
Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis.
Recio, J. A., Noonan, F. P., Takayama, H., Anver, M. R., Duray, P. H., Rush, W. L., Lindner, G., Fabo, E. C. D., DePinho, R. A., & Merlino, G. T. (2002) · PubMed · Cited by 117
Alterations of the BRAF Gene in Thyroid Tumors
Ciampi, R., & Nikiforov, Y. E. (2005) · Endocrine Pathology · doi:10.1385/ep:16:3:163 · Cited by 117
Gaggioli, C., Buscà, R., Abbe, P., Ortonne, J. P., & Ballotti, R. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00057.x · Cited by 117
Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo
Sharpless, N. E., Kannan, K., Xu, J., Bosenberg, M., & Chin, L. (2003) · Oncogene · doi:10.1038/sj.onc.1206809 · Cited by 116
Self-citationAnalysis of protein tyrosine kinase expression in melanocytic lesions by tissue array
Shen, S. S., Zhang, P. S., Eton, O. E., & Prieto, V. G. (2003) · Journal of Cutaneous Pathology · doi:10.1034/j.1600-0560.2003.00090.x · Cited by 114
Analysis of BRAF Mutation in Primary and Metastatic Melanoma
Libra, M., Malaponte, G., Navolanic, P. M., Gangemi, P., Bevelacqua, V., Proietti, L., Bruni, B., Stivala, F., Mazzarino, M. C., Travali, S., et al. (2005) · Cell Cycle · doi:10.4161/cc.4.10.2026 · Cited by 114
Crews, C. M., Alessandrini, A., & Erikson, R. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8845 · Cited by 114
Fujimura, Y., Ohno, T., Siddique, H., Lee, L., Rao, V. N., & Reddy, E. S. (1996) · PubMed · Cited by 113
Sumoylation modulates transcriptional activity of MITF in a promoter‐specific manner
Murakami, H., & Arnheiter, H. (2005) · Pigment Cell Research · doi:10.1111/j.1600-0749.2005.00234.x · Cited by 113
Analysis of the VMD2 Promoter and Implication of E-box Binding Factors in Its Regulation
Esumi, N., Oshima, Y., Li, Y., Campochiaro, P. A., & Zack, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309881200 · Cited by 113
Weber, A., Hengge, U. R., Urbanik, D., Markwart, A., Mirmohammadsaegh, A., Reichel, M. B., Wittekind, C., Wiedemann, P., & Tannapfel, A. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000101732.89463.29 · Cited by 112
Expression of Activated Akt and PTEN in Malignant Melanomas : Relationship With Clinical Outcome
Slipicevic, A., Holm, R., Nguyen, M. T. P., Bøhler, P. J., Davidson, B., & Flørenes, V. A. (2005) · American Journal of Clinical Pathology · doi:10.1309/yt58wwmta6yr1prv · Cited by 112
Berger, A. J., Kluger, H. M., Li, N., Kielhorn, E., Halaban, R., Ronai, Z. A., & Rimm, D. L. (2003) · PubMed · Cited by 111
Aoki, H., & Moro, O. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01996-3 · Cited by 111
So, H., Rho, J., Jeong, D., Park, R., Fisher, D. E., Ostrowski, M. C., Choi, Y., & Kim, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302940200 · Cited by 110
Self-citationSuppression of oncogenic NRAS by RNA interference induces apoptosis of human melanoma cells
Eskandarpour, M., Kiaii, S., Zhu, C., Castro, J., Sakko, A. J., & Hansson, J. (2005) · International Journal of Cancer · doi:10.1002/ijc.20873 · Cited by 110
Quantitative Approach to Single-Nucleotide Polymorphism Analysis Using MALDI-TOF Mass Spectrometry
Ross, P. L., Hall, L., & Haff, L. A. (2000) · BioTechniques · doi:10.2144/00293rr05 · Cited by 106
Identification of Aim-1 as the underwhiteMouse Mutant and Its Transcriptional Regulation by MITF
Du, J., & Fisher, D. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110229200 · Cited by 105
Self-citationJiao, Z., Mollaaghababa, R., Pavan, W. J., Antonellis, A., Green, E. D., & Hornyak, T. J. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00154.x · Cited by 105
Increasing Epidermal Growth Factor Receptor Expression in Human Melanocytic Tumor Progression
de Wit, P. E. J., Moretti, S., Koenders, P. G., Weterman, M. A. J., van Muijen, G. N. P., Gianotti, B., & Ruiter, D. J. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12616793 · Cited by 102
Sensorineural Deafness and Pigmentation Genes
Price, E. R., & Fisher, D. E. (2001) · Neuron · doi:10.1016/s0896-6273(01)00259-8 · Cited by 102
Self-citationBRAF and c-kit gene copy number in mutation-positive malignant melanoma
Willmore‐Payne, C., Holden, J. A., Hirschowitz, S. L., & Layfield, L. J. (2006) · Human Pathology · doi:10.1016/j.humpath.2006.01.003 · Cited by 101
Badros, A. Z., Goloubeva, O. G., Rapoport, A. P., Ratterree, B., Gahres, N., Meisenberg, B. R., Takebe, N., Heyman, M. R., Zwiebel, J. A., STREICHER, H. Z., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.381 · Cited by 101
Molven, A., Grimstvedt, M. B., Steine, S. J., Harland, M., Avril, M., Hayward, N. K., & Akslen, L. A. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20202 · Cited by 100
Bcl-2 expression in human melanocytes and melanocytic tumors.
van den Oord, J. J., Vandeghinste, N., LEY, M. D., & Wolf-Peeters, C. D. (1994) · PubMed Central · Cited by 98
Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas
Edmunds, S., Cree, I. A., Nicolantonio, F. D., Hungerford, J. L., Hurren, J., & Kelsell, D. P. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600919 · Cited by 97
Survivin, bcl-2, bax, and bcl-X Gene Expression in Sentinel Lymph Nodes From Melanoma Patients
Gradilone, A., Gazzaniga, P., Ribuffo, D., Scarpa, S., Cigna, E., Vasaturo, F., Bottoni, U., INNOCENZI, D., Calvieri, S., Scuderi, N., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.066 · Cited by 97
In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma
Robertson, G. P., Furnari, F. B., Miele, M. E., Glendening, M. J., Welch, D. R., Fountain, J. W., LUGO, T. G., Huang, H., & Cavenee, W. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9418 · Cited by 97
Baxter, L. L., & Pavan, W. J. (2003) · Gene Expression Patterns · doi:10.1016/j.modgep.2003.07.002 · Cited by 96
Kumar, R., Smeds, J., Berggren, P., Straume, O., Rozell, B. L., Akslen, L. A., & Hemminki, K. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20011120)95:6<388::aid-ijc1069>3.0.co;2-6 · Cited by 96
Plettenberg, A., Ballaun, C., Pammer, J., Mildner, M., Strunk, D., Weninger, W., & Tschachler, E. (1995) · Europe PMC (PubMed Central) · Cited by 95
Khaled, M., Larribère, L., Bille, K., Ortonne, J. P., Ballotti, R., & Bertolotto, C. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12420.x · Cited by 95
Jafari, M., Papp, T., Kirchner, S., Kiener, U., Henschler, D., Burg, G., & Schiffmann, D. (1995) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01202725 · Cited by 94
PTEN Expression in Melanoma: Relationship with Patient Survival, Bcl-2 Expression, and Proliferation
Mikhail, M., Velazquez, E., Shapiro, R. L., Berman, R. S., Pavlick, A. C., Sorhaindo, L., Spira, J., Mir, C. M., Panageas, K. S., Polsky, D., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0397 · Cited by 89
LoRusso, P. M., Krishnamurthi, S., Rinehart, J. J., Nabell, L., Croghan, G. A., Varterasian, M. L., Sadis, S., Menon, S. S., Leopold, J., & Meyer, M. B. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.3011 · Cited by 89
Low Prevalence of Germline CDKN2A and CDK4 Mutations in Patients With Early-Onset Melanoma
Tsao, H., Zhang, X., Kwitkiwski, K., Finkelstein, D. M., Sober, A. J., & Haluska, F. G. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.9.1118 · Cited by 87
Role of AP-2 in Tumor Growth and Metastasis of Human Melanoma
Bar‐Eli, M. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006377309524 · Cited by 86
Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma
Zhuang, L., Lee, C. S., Scolyer, R. A., McCarthy, S., Palmer, A. A., Zhang, X. D., Thompson, J. F., Bron, L. P., & Hersey, P. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.025957 · Cited by 85
A mutation hotspot at the p14ARF splice site
Harland, M., Taylor, C., Chambers, P. A., Kukalizch, K., Randerson‐Moor, J. A., Gruis, N. A., de Snoo, F. A., ter Huurne, J., Goldstein, A. M., Tucker, M. A., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208678 · Cited by 85
Stewart, A. L., Mhashilkar, A. M., Yang, X. H., Ekmekçioglu, S., Saito, Y., Sieger, K., Schrock, R. D., Onishi, E., Swanson, X., Mumm, J. B., et al. (2002) · Molecular Medicine · doi:10.1007/bf03402025 · Cited by 84
An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis
Bhoumik, A., Huang, T.-G., Ivanov, V. N., Gangi, L., Qiao, R., Woo, S. L. C., Chen, S., & Ronai, Z. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16081 · Cited by 84
Zhiqi, S., Soltani, M. H., Bhat, K. M. R., Sangha, N., Fang, D., Hunter, J., & Setaluri, V. (2004) · Melanoma Research · doi:10.1097/00008390-200412000-00011 · Cited by 82
Selective deletion of exon 1β of thep19ARF gene in metastatic melanoma cell lines
Kumar, R., Sauroja, I., Punnonen, K. R. A., Jansén, C. T., & Hemminki, K. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199811)23:3<273::aid-gcc11>3.0.co;2-n · Cited by 82
Chromosome 7 Aneusomy. A Marker for Metastatic Melanoma?
Udart, M., Utikal, J. S., Krähn, G. M., & Peter, R. U. (2001) · Neoplasia · doi:10.1038/sj.neo.7900156 · Cited by 82
Novel mutations in the p16/CDKN2A binding region of the cyclin-dependent kinase-4 gene.
Tsao, H., Benoit, E., Sober, A. J., Thiele, C. J., & Haluska, F. G. (1998) · PubMed · Cited by 81
Dlugosz, A. A., Hansen, L. A., Cheng, C., Alexander, N., Denning, M. F., Threadgill, D. W., Magnuson, T., Coffey, R. J., & Yuspa, S. H. (1997) · PubMed · Cited by 80
Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.
Tron, V. A., Krajewski, S., Klein-Parker, H., Li, G., Ho, V. C., & Reed, J. C. (1995) · PubMed Central · Cited by 78
Granter, S. R., Weilbaecher, K. N., Quigley, C., Fletcher, C. D. �., & Fisher, D. E. (2001) · Modern Pathology · doi:10.1038/modpathol.3880249 · Cited by 76
Self-citationThe role of Bcl-2 family members in the progression of cutaneous melanoma
Bush, J., & Li, G. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1025874502181 · Cited by 75
BRAF as a melanoma susceptibility candidate gene?
Laud, K., Kannengiesser, C., Avril, M., Chompret, A., Stoppa‐Lyonnet, D., Desjardins, L., Eychène, A., Démenais, F., Lenoir, G., & Paillerets, B. B. (2003) · PubMed · Cited by 75
Udart, M., Utikal, J. S., Krähn, G. M., et al. (2001) · PubMed · doi:10.1038/sj.neo/7900156 · Cited by 74
PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines
Pollock, P. M., Walker, G. J., Glendening, J. M., Noy, T. Q., Bloch, N. C., Fountain, J. W., & Hayward, N. K. (2002) · Melanoma Research · doi:10.1097/00008390-200212000-00006 · Cited by 74
Vetrini, F., Auricchio, A., Du, J., Angeletti, B., Fisher, D. E., Ballabio, A., & Marigo, V. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6550-6559.2004 · Cited by 74
Self-citationRecurrent Patterns of Dual RB and p53 Pathway Inactivation in Melanoma
Yang, G., Rajadurai, A., & Tsao, H. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23931.x · Cited by 73
Role of Epidermal Growth Factor Receptor Signaling in RAS-Driven Melanoma
Bardeesy, N. M., Kim, M., Xu, J., Kim, R.-S., Shen, Q. “., Bosenberg, M., Wong, W. H., & Chin, L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.4176-4188.2005 · Cited by 70
Self-citationYasumoto, K., Yokoyama, K., Shibata, K., Tomita, Y., & Shibahara, S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1833 · Cited by 69
The Xmrk receptor tyrosine kinase is activated in Xiphophorus malignant melanoma.
Wittbrodt, J., Lammers, R., Malitschek, B., Ullrich, A., & Schartl, M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05518.x · Cited by 64
Constitutive Activation of the Mitogen-Activated Protein Kinase Signaling Pathway in Acral Melanomas
Takata, M., Goto, Y., Ichii, N., Yamaura, M., Murata, H., Koga, H., Fujimoto, A., & Saida, T. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23812.x · Cited by 63
p16(INK4a) and p53 deficiency cooperate in tumorigenesis.
Sharpless, N. E., Alson, S., Chan, S., Silver, D. P., Castrillón, D. H., & DePinho, R. A. (2002) · PubMed · Cited by 63
Expression of c‐kit (CD117) in Spitz nevus and malignant melanoma
Zhu, Y. I., & Fitzpatrick, J. E. (2005) · Journal of Cutaneous Pathology · doi:10.1111/j.0303-6987.2006.00420.x · Cited by 62
Inhibition of Melanoma Growth and Metastasis by ATF2-Derived Peptides
Bhoumik, A., Gangi, L., & Ronai, Z. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0714 · Cited by 58
Adachi, S., Morii, E., Kim, D.-K., Ogihara, H., Jippo, T., Ito, A., Lee, Y., & Kitamura, Y. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.855 · Cited by 57
Namiki, T., YANAGAWA, S., Izumo, T., Ishikawa, M., Tachibana, M., Kawakami, Y., Yokozeki, H., Nishioka, K., & Kaneko, Y. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.06.004 · Cited by 56
Casula, M., Colombino, M., Satta, M. P., Cossu, A., Ascierto, P. A., Bianchi‐Scarrà, G., Castiglia, D., Budroni, M., Rozzo, C., Manca, A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.112 · Cited by 56
Speiser, D. E., Pittet, M. J., Rimoldi, D., Guillaume, P., Luescher, I. F., Líénard, D., Lejeune, F. J., Cerottini, J., & Romero, P. J. (2003) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.09.010 · Cited by 55
Tang, Y., Kim, M., Carrasco, D. R., Kung, A. L., Chin, L., & Weissleder, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0027 · Cited by 52
Self-citationChanges in Different Melanocyte Populations During Hair Follicle Involution (Catagen)
Sharov, A., Tobin, D. J., Sharova, T. Y., Atoyan, R., & Botchkarev, V. A. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23959.x · Cited by 51
Spontaneous and UV Radiation–Induced Multiple Metastatic Melanomas in Cdk4R24C/R24C/TPras Mice
Hacker, E., Muller, H. K., Irwin, N., Gabrielli, B. G., Lincoln, D. J., Pavey, S. J., Powell, M. B., Malumbres, M., Barbacid, M., Hayward, N. K., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3196 · Cited by 51
Flaherty, K. T., Redlinger, M., Schuchter, L. M., Lathia, C. D., Weber, B., & O'Dwyer, P. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.3037 · Cited by 50
Telomeres, stem cells, senescence, and cancer
Sharpless, N. E., & DePinho, R. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420761 · Cited by 49
Animal models of melanoma: Recent advances and future prospects
Bardeesy, N. M., Wong, K., DePinho, R. A., & Chin, L. (2000) · Advances in cancer research · doi:10.1016/s0065-230x(00)79004-x · Cited by 47
Self-citationSteingrı́msson, E., Nii, A., Fisher, D. E., Ferré-D’Amaré, A. R., McCormick, R. J., Russell, L. B., Burley, S. K., Ward, J. M., Jenkins, N. A., & Copeland, N. G. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01018.x · Cited by 47
Self-citationMelanoma Cell Autonomous Growth: The Rb/E2F Pathway
Halaban, R. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006396104073 · Cited by 46
CTLA-4 Blockade: Unveiling Immune Regulation
Dranoff, G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.923 · Cited by 46
Mutated N-ras upregulates Bcl-2 in human melanoma in vitro and in SCID mice
Borner, C., Schlagbauer‐Wadl, H., Fellay, I., Selzer, E., Polterauer, P., & Jansen, B. (1999) · Melanoma Research · doi:10.1097/00008390-199908000-00002 · Cited by 45
Mcl-1 blocks radiation-induced apoptosis and inhibits clonogenic cell death.
Skvara, H., Thallinger, C., Wacheck, V., Monia, B. P., Pehamberger, H., Jansen, B., & Selzer, E. (2005) · PubMed · Cited by 45
Morii, E., Oboki, K., Ishihara, K., Jippo, T., Hirano, T., & Kitamura, Y. (2004) · Blood · doi:10.1182/blood-2004-01-0247 · Cited by 44
Smith, A. G., Box, N. F., Marks, L. H., Chen, W., Smit, D. J., Wyeth, J. R., Huttley, G. A., Easteal, S., & Sturm, R. A. (2001) · Gene · doi:10.1016/s0378-1119(01)00791-0 · Cited by 43
Ogihara, H., Kanno, T., Morii, E., Kim, D., Lee, Y., Sato, M., Kim, W., Nomura, S., Ito, Y., & Kitamura, Y. (1999) · Oncogene · doi:10.1038/sj.onc.1202844 · Cited by 43
Partington, G. A., Fuller, K., Chambers, T. J., & Pondel, M. D. (2003) · Bone · doi:10.1016/j.bone.2003.11.010 · Cited by 40
The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer
Xing, M. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02332.x · Cited by 39
O’Hagan, R. C., Brennan, C., Strahs, A. L., Zhang, X., Kannan, K., Donovan, M., Cauwels, C., Sharpless, N. E., Wong, W. H., & Chin, L. (2003) · PubMed · Cited by 39
Self-citationLipocalin-type prostaglandin D synthase as a melanocyte marker regulated by MITF
Takeda, K., Yokoyama, S., Aburatani, H., Masuda, T., Han, F., Yoshizawa, M., Yamaki, N., Yamamoto, H., Eguchi, N., Urade, Y., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.125 · Cited by 38
Halaban, R., Böhm, M., Dotto, G. P., Moellmann, G. E., Cheng, E., & Zhang, Y. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12348972 · Cited by 37
Ki-67, Bcl-2 and p53 expression in primary and metastatic melanoma
Ilmonen, S., Hernberg, M., Pyrhönen, S. O., Tarkkanen, J., & Asko-Seljavaara, S. L. (2005) · Melanoma Research · doi:10.1097/00008390-200510000-00005 · Cited by 35
Flipping the oncogene switch: illumination of tumor maintenance and regression
Chin, L., & DePinho, R. A. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01968-x · Cited by 34
Self-citationMurakami, M., Ikeda, T., Saito, T., Ogawa, K., Nishino, Y., Nakaya, K., & Funaba, M. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.04.010 · Cited by 33
Sato, M., Morii, E., Takebayashi‐Suzuki, K., Yasui, N., Ochi, T., Kitamura, Y., & Nomura, S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9918 · Cited by 33
CCI-779 in metastatic melanoma: A phase II trial of the California Cancer Consortium
Margolin, K. A., Longmate, J., Baratta, T., Synold, T. W., Weber, J. S., Gajewski, T. F., Quirt, I. C., Christensen, S. M., & Doroshow, J. H. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.7523 · Cited by 31
No Evidence for BRAF as a Melanoma/Nevus Susceptibility Gene
Jackson, S., Harland, M., Turner, F., Taylor, C., Chambers, P. A., Randerson‐Moor, J. A., Swerdlow, A. J., dos‐Santos‐Silva, I., Beswick, S., Bishop, D. T., et al. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0568 · Cited by 29
From Integrated Genomics to Tumor Lineage Dependency
Garraway, L. A., & Sellers, W. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4604 · Cited by 28
Self-citationHuang, T., Rauth, S., & Gupta, T. K. D. (1996) · PubMed · Cited by 23
Peptide vaccine trials for melanoma: preclinical background and clinical results
Talebi, T. N., & Weber, J. S. (2003) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.09.007 · Cited by 22
Regulation of the Murine TRACP Gene Promoter
Cassady, A. I., Luchin, A., Ostrowski, M. C., & Hume, D. A. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.10.1901 · Cited by 17
Expression of Activated Akt and PTEN in Malignant Melanomas : Relationship With Clinical Outcome
Slipicevic, A., Holm, R., Nguyen, M. T. P., Bøhler, P. J., Davidson, B., & Flørenes, V. A. (2005) · American Journal of Clinical Pathology · doi:10.1309/yt58-wwmt-a6yr-1prv · Cited by 17
Contribution of the SgIGSF adhesion molecule to survival of cultured mast cells in vivo
Ito, A., Koma, Y.-I., Watabe, K., Jippo, T., Wakayama, T., Iseki, S., & Kitamura, Y. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.172 · Cited by 16
FGF‐2 blocks TGF‐β1‐mediated suppression of Bcl‐2 in normal melanocytes
von Willebrand, M., Köhler, K., Alanko, T., Laiho, M., & Saksela, O. (2005) · Experimental Dermatology · doi:10.1111/j.0906-6705.2005.00277.x · Cited by 12
An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis
Bhoumik, A., Huang, T., Ivanov, V. N., Gangi, L., Qiao, R., Woo, S. L. C., Chen, S., & Ronai, Z. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200216081 · Cited by 8
Merlino, G. T. (2005) · Nature · doi:10.1038/436033a · Cited by 6
Cited by
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Self-citationIdentification of cells initiating human melanomas
Schatton, T., Murphy, G. F., Frank, N. Y., Yamaura, K., Waaga-Gasser, A. M., Gasser, M., Zhan, Q., Jordan, S., Duncan, L. M., Weishaupt, C., et al. (2008) · Nature · doi:10.1038/nature06489 · Cited by 1,415
Melanocyte biology and skin pigmentation
Lin, J. Y., & Fisher, D. E. (2007) · Nature · doi:10.1038/nature05660 · Cited by 1,379
Self-citationBrafV600E cooperates with Pten loss to induce metastatic melanoma
Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189
Central role of p53 in the suntan response and pathologic hyperpigmentation
Cui, R., Widlund, H. R., Feige, E., Lin, J. Y., Wilensky, D. L., Igras, V. E., D'Orazio, J., Fung, C. Y., Schanbacher, C. F., Granter, S. R., et al. (2007) · Cell · doi:10.1016/j.cell.2006.12.045 · Cited by 657
“, 2002) since the entire pigmentation machinery, including tyrosinase, is thought to be transcriptionally activated by MITF (Chin et al., 2006).”
Self-citation
Metadata
- Authors
- Chin, L., Garraway, L. A., & Fisher, D. E.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2006-08-15
- Volume
- 20
- Issue
- 16
- Pages
- 2149-2182
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2161275429
- Cited by
- 511
- References
- 373
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.